Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden.

Lind, Marcus; Matsson, Per-Olov; Linder, Ragnar; Svenningsson, Irene; Jørgensen, Leif; Ploug, Uffe J; Gydesen, Helge; Dorkhan, Mozhgan; Larsen, Sara; Johansson, Gunnar

Lind, Marcus; Matsson, Per-Olov; Linder, Ragnar; Svenningsson, Irene; Jørgensen, Leif; Ploug, Uffe J; Gydesen, Helge; Dorkhan, Mozhgan; Larsen, Sara; Johansson, Gunnar.

Afiliação

Lind M; Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden. lind.marcus@telia.com.
Matsson PO; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com.
Linder R; Domnarvet VC, Borlänge, Sweden.
Svenningsson I; Pygargus, Stockholm, Sweden.
Jørgensen L; Research and Development Unit, Primary Health Care, Närhälsan, Vänersborg, Sweden.
Ploug UJ; IMS Health, Stockholm, Sweden.
Gydesen H; Novo Nordisk A/S, Søborg, Denmark.
Dorkhan M; Novo Nordisk A/S, Søborg, Denmark.
Larsen S; Novo Nordisk Scandinavia AB, Malmö, Sweden.
Johansson G; Novo Nordisk Scandinavia AB, Malmö, Sweden.

Diabetes Ther ; 7(2): 321-33, 2016 Jun.

Article em En | MEDLINE | ID: mdl-27216947

Palavras-chave

Liraglutide; Real-world evidence; Sitagliptin; Sweden; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Diabetes Ther Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google